Skip to content

Category: tumorsSyndicate content

New Notre Dame study provides insights into the molecular basis of tumor cell behavior

November 5, 2009

A new study by a team of researchers led by Crislyn D'Souza-Schorey, associate professor of biological sciences at the University of Notre Dame, sheds light on the molecular basis by which tumor c

Blood vessels might predict prostate cancer behavior

November 3, 2009

COLUMBUS, Ohio -- A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave.

Aiming to avoid damage to neurocognitive areas of the brain during cranial radiation

November 3, 2009

Radiation oncologists at Rush University Medical Center are intent on finding ways to avoid damage to the critically important hippocampus and limbic circuit of the brain when cranial radiation is

Experimental agent reduces breast cancer metastasis to bone

November 3, 2009

Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer.

Duke develops nano-scale drug delivery for chemotherapy

November 1, 2009

DURHAM, N.C. -- Going smaller could bring better results, especially when it comes to cancer-fighting drugs.

Th17 cells summon an immune system strike against cancer

October 29, 2009

HOUSTON - A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists from The

UT Southwestern researchers use drug-radiation combo to eradicate lung cancer

October 29, 2009

Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.

Adding tools against breast tumors

October 27, 2009

At the end of a 10-year, coast-to-coast study of women with an unusual form of breast cancer, Richard J.

Alcohol activates cellular changes that make tumor cells spread

October 26, 2009

Alcohol consumption has long been linked to cancer and its spread, but the underlying mechanism has never been clear.

Chemosensitivity of cancer cells depends on their protein dependency

October 26, 2009

Two different anti-apoptotic proteins support cancer cell survival via an identical mechanism, yet differ in their sensitivity to chemotherapeutic drugs, report Brunelle et al.

Testicular tumors may explain why some diseases are more common in children of older fathers

October 25, 2009

A rare form of testicular tumour has provided scientists with new insights into how genetic changes (mutations) arise in our children. The research, funded by the Wellcome Trust and the Danish Cancer Society, could explain why certain diseases are more common in the children of older fathers.

Seeing previously invisible molecules for the first time

October 23, 2009

A team of Harvard chemists led by X. Sunney Xie has developed a new microscopic technique for seeing, in color, molecules with undetectable fluorescence. The room-temperature technique allows researchers to identify previously unseen molecules in living organisms and offers broad applications in biomedical imaging and research.

Sanford Barsky, M.D., University of Nevada School of Medicine and Nevada Cancer Institute faculty member publishes scientific paper in the journal Nature

October 23, 2009

RENO/LAS VEGAS, Nev. -- Sanford Barsky, M.D., who holds faculty positions at the University of Nevada School of Medicine as chair of the pathology department and Nevada Cancer Institute chief of pathology, is part of a team that has a paper on transgenic mouse mammary tumors with direct relevance to human breast cancer published in the October 22 issue of the scientific journal Nature.

New therapy for vasculitis will help patients avoid infertility and cancer

October 17, 2009

Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy. The news will be presented October 18 at the annual meeting of the American College of Rheumatology in Philadelphia.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.